Sean Lal

2.8k total citations · 1 hit paper
68 papers, 1.5k citations indexed

About

Sean Lal is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Sean Lal has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cardiology and Cardiovascular Medicine, 30 papers in Molecular Biology and 15 papers in Surgery. Recurrent topics in Sean Lal's work include Cardiomyopathy and Myosin Studies (17 papers), Cardiovascular Function and Risk Factors (15 papers) and Congenital heart defects research (7 papers). Sean Lal is often cited by papers focused on Cardiomyopathy and Myosin Studies (17 papers), Cardiovascular Function and Risk Factors (15 papers) and Congenital heart defects research (7 papers). Sean Lal collaborates with scholars based in Australia, United States and United Kingdom. Sean Lal's co-authors include Cristobal G. dos Remedios, Nelson Wang, Amy Li, Jordan Fulcher, Ian Wilcox, David S. Celermajer, Michele McGrady, James W. McNamara, Richard I. Christopherson and Roger Cooke and has published in prestigious journals such as Circulation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Sean Lal

64 papers receiving 1.5k citations

Hit Papers

Tricuspid regurgitation is associated with increased mort... 2018 2026 2020 2023 2018 50 100 150 200

Peers

Sean Lal
Dominik Rath Germany
Achim Obergfell Switzerland
Vlad C. Vasile United States
Kishan S. Parikh United States
N. Chung United Kingdom
Dominik Rath Germany
Sean Lal
Citations per year, relative to Sean Lal Sean Lal (= 1×) peers Dominik Rath

Countries citing papers authored by Sean Lal

Since Specialization
Citations

This map shows the geographic impact of Sean Lal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Lal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Lal more than expected).

Fields of papers citing papers by Sean Lal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sean Lal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Lal. The network helps show where Sean Lal may publish in the future.

Co-authorship network of co-authors of Sean Lal

This figure shows the co-authorship network connecting the top 25 collaborators of Sean Lal. A scholar is included among the top collaborators of Sean Lal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sean Lal. Sean Lal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patanwala, Asad E., et al.. (2025). Implementing CYP2C19-guided clopidogrel therapy: a scoping review of pharmacogenomic testing services. The Pharmacogenomics Journal. 25(3). 12–12.
2.
Zhang, Yunwei, Dylan Harney, Holly P. McEwen, et al.. (2025). Left ventricular myocardial molecular profile of human diabetic ischaemic cardiomyopathy. EMBO Molecular Medicine. 17(9). 2483–2524. 1 indexed citations
3.
Koay, Yen Chin, Yang Cao, Xiaosuo Wang, et al.. (2025). The Heart Has Intrinsic Ketogenic Capacity that Mediates NAD + Therapy in HFpEF. Circulation Research. 136(10). 1113–1130. 2 indexed citations
5.
Refaat, Ahmed, et al.. (2025). Acetylcholine-loaded nanoparticles protect against doxorubicin-induced toxicity in in vitro cardiac spheroids. Biofabrication. 17(2). 25023–25023. 1 indexed citations
6.
Wang, Nelson, et al.. (2024). Echocardiographic Predictors of Cardiovascular Outcome in Heart Failure with Preserved Ejection Fraction. European Journal of Heart Failure. 26(8). 1778–1787. 9 indexed citations
8.
Li, Amy, Mengbo Li, Yen Chin Koay, et al.. (2024). Myocardial Posttranscriptional Landscape in Peripartum Cardiomyopathy. Circulation Heart Failure. 17(12). e011725–e011725. 2 indexed citations
9.
Li, Mengbo, Benjamin L. Parker, Yen Chin Koay, et al.. (2024). Proteomic and metabolomic analyses of the human adult myocardium reveal ventricle-specific regulation in end-stage cardiomyopathies. Communications Biology. 7(1). 1666–1666. 2 indexed citations
10.
Cordina, Rachael, et al.. (2024). Recurrent immunosuppressive-responsive myocarditis in a patient with desmoplakin cardiomyopathy: a case report. European Heart Journal - Case Reports. 8(3). ytae129–ytae129. 5 indexed citations
11.
Dennis, Mark, Aidan Burrell, Sean Lal, et al.. (2024). Cardiogenic Shock Challenges and Priorities: A Clinician Survey. Heart Lung and Circulation. 33(8). 1227–1231. 1 indexed citations
12.
Wang, Ziyu, Hugh S. Paterson, Matthew S. Adams, et al.. (2024). Preventing Sheep Carotid Artery Spasm for Vascular Graft Surgery and Computed Tomography Angiography. Tissue Engineering Part C Methods. 30(8). 335–342.
13.
Singer, Emma S., Mira Holliday, Sean Lal, et al.. (2023). The burden of splice-disrupting variants in inherited heart disease and unexplained sudden cardiac death. npj Genomic Medicine. 8(1). 29–29. 5 indexed citations
14.
Holliday, Mira, Emma S. Singer, Samantha Barratt Ross, et al.. (2021). Transcriptome Sequencing of Patients With Hypertrophic Cardiomyopathy Reveals Novel Splice-Altering Variants in MYBPC3. Circulation Genomic and Precision Medicine. 14(2). e003202–e003202. 18 indexed citations
15.
Noor, Asif, Karen Alt, Sean Lal, et al.. (2021). Collagen‐Targeted Peptides for Molecular Imaging of Diffuse Cardiac Fibrosis. Journal of the American Heart Association. 10(18). e022139–e022139. 17 indexed citations
16.
Li, Mengbo, Benjamin L. Parker, Benjamin Hunter, et al.. (2020). Core functional nodes and sex-specific pathways in human ischaemic and dilated cardiomyopathy. Nature Communications. 11(1). 2843–2843. 57 indexed citations
17.
Li, Amy, et al.. (2019). Pathogenesis and pathophysiology of heart failure with reduced ejection fraction: translation to human studies. Heart Failure Reviews. 24(5). 743–758. 29 indexed citations
18.
Cao, Jacob, Ruilong Zhao, Kim H. Chan, et al.. (2018). Abstract 15185: The Pattern of Atrial Fibrillation is Relevant to Predicting Thromboembolic Risk - is It Time to Rethink Risk Scores?. Circulation. 1 indexed citations
19.
Vikhorev, Petr G., O’Neal Copeland, Sawa Kostin, et al.. (2017). Abnormal contractility in human heart myofibrils from patients with dilated cardiomyopathy due to mutations in TTN and contractile protein genes. Scientific Reports. 7(1). 14829–14829. 40 indexed citations
20.
Koopmann, Tamara T., Michiel Adriaens, Perry D. Moerland, et al.. (2014). Genome-Wide Identification of Expression Quantitative Trait Loci (eQTLs) in Human Heart. PLoS ONE. 9(5). e97380–e97380. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026